How To Create An Awesome Instagram Video About Tumor Treating Fields Mesothelioma

2023-09-09T00:45:42Z

Airmeat73: Die Seite wurde neu angelegt: „Tumor Treating Fields Mesothelioma Tumor treating fields mesothelioma is a brand new therapy that uses alternating electric fields to limit cancer g…“

Tumor Treating Fields Mesothelioma Tumor treating fields mesothelioma is a brand new therapy that uses alternating electric fields to limit cancer growth. It is used in combination with chemotherapy to treat pleural cancer. The FDA approved TTFields in conjunction with pemetrexed and Cisplatin in the year 2019 following the successful STELLAR trial. Patients can consult their physician for this treatment. Disrupting Cell Division TTFields uses different electrical fields that disrupt cancer cell protein and block the cells from multiplying. This can prevent mesothelioma cells from expanding or spreading to other organs within the body. The TTFields stimulate the release of proteins that kill cancerous cells and help the immune system in fighting mesothelioma tumors. During treatment patients wear a small device that has pads insulated with adhesive that adhere to the skin. The device is able to deliver a low-intensity electrical current and patients are able to control how much treatment they receive. A mesothelioma treatment lasts around 30 minutes. Patients can have TTFields treatment at various times throughout the day. A TTFields study that was published in 2021 discovered that the intensity of the electrical field of 100-300 kilohertz was able to stop the division of cancer cells and cause them to die. The study covered a variety of types of cancer cells and found that the electrical fields killed all of them regardless of their cell structure. The study's authors recommended combining TTFields with chemotherapy for mesothelioma. Novocure's TTFields product, NovoTTF-100L, was approved by the FDA in the year 2019 to treat pleural mesothelioma unresectable. It is now accessible through mesothelioma physicians at certified medical centers across the U.S., including the West Cancer Center in Memphis. The NovoTTF-100L device, now called Optune Lua, has been used to treat mesothelioma in combination with platinum-based chemotherapy. Patients with mesothelioma have reported a longer time to live when the TTFields therapy is paired with chemotherapy. Another study published in the journal "Lung Cancer" reported that TTFields therapy works well with chemotherapy. In [https://www.mesotheliomatreatment.top/ tumor treating fields mesothelioma] discovered that the combination of chemotherapy and TTFields reduced the amount of malignant mesothelioma cells in animals by more than 80%. The study also demonstrated that combing these treatments boosted the production proteins that kill mesothelioma cancer cells and decrease the amount of cancerous DNA in your body. The TTFields procedure is a relatively recent treatment and many mesothelioma doctors do not recommend it for pleural malignant mesothelioma. However, patients may still be able to avail this treatment option through clinical trials or mesothelioma clinics that are accredited by Novocure. Stalling Tumor Development When mesothelial cancer cells multiply and exceed their normal lifespan they develop mutated cells and result in an overabundance which grows and expands throughout the body. Treatment for tumors prevents mesothelial cell duplicates, which stops mesothelioma from expanding and growing. The TTFields device, worn on the chest as a vest, creates a series of electrical fields that can disrupt protein and kill cancer cells and slow the development of tumors. The device comes with insulated pads that stick to the skin. Patients or health care professionals can apply them at home. Doctors suggest combining TTFields therapy with chemotherapy for the best results. The combination increases production of proteins which destroy cancer cells, and decreases cancer cells' ability to repair DNA damage from chemotherapy drugs. This allows the chemotherapies perform even more effectively and increases survival rates for mesothelioma. In the most recent STELLAR trial, the combination of TTFields therapy and chemotherapy significantly increased survival for mesothelioma sufferers. In 2019, the FDA approved the NovoTTF 100L System, now available under Optune Lua for use with pemetrexed, cisplatin, or carboplatin as a first-line treatment for malignant pleural melanoma that is not surgically resectable. Researchers have discovered that TTFields therapy works against mesothelioma because it interrupts cell division. The TTFields treatment causes cancer cells to break down through a process known as mitosis, and then the cell debris is absorbed by surrounding tissues, which inhibits the development of new tissue. Mitosis also prevents mesothelioma cells from repairing damaged DNA, and makes cells more susceptible to radiation treatments. The TTFields therapy can also reduce the flow of blood from tumors by suppression of vascular endothelial-growth factor (VEGF) and the rise of hypoxia-inducible factors-1 beta or HIF-1a. HIF-1a is linked to cancer cells angiogenesis. Consult your physician if you have been diagnosed with mesothelioma. Many mesothelioma specialists have partnered with Novocure on clinical trials to determine the efficacy of this revolutionary treatment. To find out more about how mesothelioma TTFields could help your treatment plan get in touch with a Novocure certified specialist at one of the more than 1,300 U.S. treatment centers. Killing Tumor Cells Tumor treating fields for treating tumors (TTFields) which transmit electrical waves throughout the body. They disrupt cell division and kill cancer cells. TTFields are low intensity and intermediate frequency electrical fields that alternatingly target cancerous cells without harming healthy ones. These electric fields also reduce DNA repair and boost cell defenses, making it more difficult for cancerous cells to survive. TTF is a non-invasive treatment and has few side effects other than mild skin irritation. Scientists think TTFields work by interrupting mitosis, the process where cells divide into two identical new cells. Normal cells have controls to limit the rate of mitosis. However cancerous tumors of malignancy are able to breach these limitations and multiply at a rapid rate. TTFields interferes with this process by blocking signals that regulate mitosis in mesothelioma cancer cells. In the STELLAR study, TTFields in combination with chemotherapy improved survival rates for mesothelioma. Mesothelioma survivors who received TTFields along with maintenance cycles of chemotherapy lived six months longer on average than those who just received chemotherapy. In a different study, it was found that TTFields could increase the effectiveness of certain chemotherapy drugs known as platinum-based treatments. These platinum-based therapies kill mesothelioma by targeting mitochondria. This is where the energy of cancerous cells originates. When TTFields are utilized in conjunction with these chemotherapies, the combination may result in greater DNA damage and faster death of cancer cells. TTFields can also enhance the effects of radiation therapy in certain instances. Researchers have observed that the combination of TTFields and radiation therapy can produce an "synergistic" effect. This means that the combination treatment improves the sensitivity tumor cells to radiation. Currently, TTFields are available at some mesothelioma centers. A mesothelioma expert can determine if you're suitable for this treatment. If you're eligible an attorney for mesothelioma can assist you in getting access to treatment that can include TTFields along with chemotherapy. If you are an active military veteran mesothelioma lawyer will help you get treatment that is covered under your VA health benefits. Side Effects The TT fields therapy destroys cancer cells by creating an electrical field that blocks the cell's ability to divide. This may slow the growth of a tumor and stop it from spreading to other parts of the body. The TT fields device is non-invasive, which means it does not damage the tissue surrounding it or cause discomfort. This is a different approach than conventional chemotherapy, which involves radiation and injections into the intravenous vein which can result in serious side effects. In an investigation in which patients received a combination of TT fields and temozolomide showed improvement in survival that was comparable to those of people treated with chemo alone. Doctors attributed the improved survival to the TT fields their ability to enhance the efficacy of chemo and lessen the risk of side effects. Mesothelioma cells may transform into cancerous cells, and then reproduce in uncontrolled ways to create an aggressive tumor that takes over the organs of your body. By halting cell division, mesothelioma treatment like TT fields prevent mesothelioma cancer cells from reproducing and limiting your body's normal functions. During a mesothelioma study, patients who received TT-fields in conjunction with chemo experienced an average survival rate (18.2 months). Those who received TT fields but not chemo had a survival rate of 12.1. Tumor-treating fields can be applied to the pleura, or the thin lining of your lungs, whether on your chest or abdominal wall. The device is small enough to wear for up to 18 hours each day, even during sleep. This allows patients to maintain their life and work even while they undergo treatment. TT fields can be incorporated with conventional chemotherapy, immunotherapy or other mesothelioma treatments. Mesothelioma patients interested in TT fields should discuss this possibility with their mesothelioma specialist who will explain eligibility requirements and predicted benefits for the patient's particular situation.

Penexchange Wiki - Benutzerbeiträge [de]

How To Create An Awesome Instagram Video About Tumor Treating Fields Mesothelioma